Ef. Juniper et al., MEASURING QUALITY-OF-LIFE IN CHILDREN WITH RHINOCONJUNCTIVITIS, Journal of allergy and clinical immunology, 101(2), 1998, pp. 163-170
Objective: The objective of this study was to develop, pretest, and va
lidate a questionnaire to measure quality of life in children with sea
sonal allergic rhinoconjunctivitis (SAR). Methods (development study):
Thirty-four children with SAR were enrolled from summer camps, notice
s in the media, and an allergy clinic (Southern Ontario). After genera
ting a pool of 48 potentially important quality of life items, the chi
ldren identified the ones that they experienced with their SAR and sco
red each for bother (1 = a little bothered to 4 = extremely bothered).
Items identified most frequently and with the highest bother score we
re included in the Paediatric Rhinoconjunctivitis Quality of Life Ques
tionnaire (PRQLQ). The PRQLQ was pretested for ease completion and acc
uracy of understanding. Results (development study): The PRQLQ has 23
items in five domains (nose symptoms, eye symptoms, practical problems
, other symptoms, and activities). Responses are given on a seven-poin
t scale, and children are asked to score their experiences during the
previous 7 days. Methods (validation study): Seventy-five children wit
h symptomatic SAR mere enrolled from notices in the media and a pediat
ric allergy clinic (Austin, Tex.). A single cohort design was used, wi
th children assessed at 0, 1, and 3 weeks. The PRQLQ was administered
to the children by a trained interviewer at 1 and 3 weeks. A conventio
nal nasal symptom daily diary was completed for 1 week before each of
these clinic visits. Global ratings were completed at the final visit.
Results (validation study): In patients who were stable between clini
c visits, the PRQLQ demonstrated good reliability (intraclass correlat
ion coefficient = 0.93). The questionnaire was very responsive to chan
ge (p < 0.001) and was able to differentiate between patients who were
in a stable clinical state and those whose clinical state changed bet
ween visits (p = 0.005). Correlations between the PRQLQ and diary scor
es were close to predicted and supported both the cross-sectional and
longitudinal validity of the PRQLQ. Conclusions: The PRQLQ measures th
e quality of life impairments important to children with SAR. Children
provide reliable and accurate responses, the measurement properties a
re strong, and the questionnaire can be used with confidence in clinic
al trials, clinical practice, and surveys.